Alert button
Picture for Jodi M. Carter

Jodi M. Carter

Alert button

Automated Scoring of Nuclear Pleomorphism Spectrum with Pathologist-level Performance in Breast Cancer

Dec 24, 2020
Caner Mercan, Maschenka Balkenhol, Roberto Salgado, Mark Sherman, Philippe Vielh, Willem Vreuls, Antonio Polonia, Hugo M. Horlings, Wilko Weichert, Jodi M. Carter, Peter Bult, Matthias Christgen, Carsten Denkert, Koen van de Vijver, Jeroen van der Laak, Francesco Ciompi

Figure 1 for Automated Scoring of Nuclear Pleomorphism Spectrum with Pathologist-level Performance in Breast Cancer
Figure 2 for Automated Scoring of Nuclear Pleomorphism Spectrum with Pathologist-level Performance in Breast Cancer
Figure 3 for Automated Scoring of Nuclear Pleomorphism Spectrum with Pathologist-level Performance in Breast Cancer
Figure 4 for Automated Scoring of Nuclear Pleomorphism Spectrum with Pathologist-level Performance in Breast Cancer

Nuclear pleomorphism, defined herein as the extent of abnormalities in the overall appearance of tumor nuclei, is one of the components of the three-tiered breast cancer grading. Given that nuclear pleomorphism reflects a continuous spectrum of variation, we trained a deep neural network on a large variety of tumor regions from the collective knowledge of several pathologists, without constraining the network to the traditional three-category classification. We also motivate an additional approach in which we discuss the additional benefit of normal epithelium as baseline, following the routine clinical practice where pathologists are trained to score nuclear pleomorphism in tumor, having the normal breast epithelium for comparison. In multiple experiments, our fully-automated approach could achieve top pathologist-level performance in select regions of interest as well as at whole slide images, compared to ten and four pathologists, respectively.

* 16 pages, 11 figures 
Viaarxiv icon